HCW Biologics Inc. (HCWB) News
Track canonical SquawkNews coverage tagged to HCWB, HCW Biologics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
HCW Biologics reports Q2 2026 business and clinical highlights
HCW Biologics (HCWB) reports second quarter 2026 business and clinical development highlights and financial results, according to TradeXchange Newsdesk.
EQUITY | Aug 14, 2026, 07:15 PM UTC
L
HCWB - HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
HCWB - HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
EQUITY | Jul 29, 2026, 01:06 PM UTC
L
HCW Biologics Regains Nasdaq Compliance After Announcing 1-For-6 Reverse Stock Split, Effective June 30
HCW Biologics Inc. (the "Company" or "HCW Biologics") (Nasdaq: HCWB ), a U.S.-based clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by ch
EQUITY | Jun 30, 2026, 12:26 PM UTC
L
HCWB Announces Reverse Split
HCW Biologics announces a 1-for-6 reverse stock split effective June 30, 2026
EQUITY | Jun 26, 2026, 12:55 PM UTC